Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 1	2025-07-03		NCT04721015

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340

33 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HM - Hopital de la Timone /ID# 225779	Marseille	France	1
Asan Medical Center /ID# 231886	Seoul	South Korea	1
Austin Health /ID# 225638	Heidelberg	Australia	1
Carolina BioOncology Institute /ID# 225358	Huntersville	United States	1
Centre Georges François Leclerc /ID# 226760	Dijon	France	1
Dana-Farber Cancer Institute /ID# 231209	Boston	United States	1
Duplicate_National Hospital Organization Shikoku Cancer Center /ID# 240821	Matsuyama	Japan	1
Hospital Universitario 12 de Octubre /ID# 225977	Madrid	Spain	1
Hospital Universitario Fundacion Jimenez Diaz /ID# 225975	Madrid	Spain	1
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 226096	Majadahonda	Spain	1
Hospital Universitario Vall d'Hebron /ID# 225976	Barcelona	Spain	1
Hospital Universitario Virgen de la Victoria /ID# 225978	Málaga	Spain	1
Institut Bergonie /ID# 225778	Bordeaux	France	1
Institut Claudius Regaud /ID# 225780	Toulouse	France	1
Institut Curie /ID# 225829	Paris	France	1
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 243345	Kaohsiung City	Taiwan	1
Lifespan Cancer Institute at Rhode Island Hospital /ID# 226145	Providence	United States	1
Linkou Chang Gung Memorial Hospital /ID# 225946	Taoyuan City	Taiwan	1
National Cancer Center /ID# 231887	Goyang-si	South Korea	1
National Cancer Center Hospital /ID# 225724	Chuo-ku	Japan	1
National Cancer Center Hospital East /ID# 225725	Kashiwa-shi	Japan	1
National Cheng Kung University Hospital /ID# 225944	Tainan	Taiwan	1
National Hospital Organization Kyushu Cancer Center /ID# 240761	Fukuoka	Japan	1
National Taiwan University Hospital - Hsinchu branch /ID# 243610	Hsinchu	Taiwan	1
NHO Nagoya Medical Center /ID# 244412	Nagoya	Japan	1

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Clinical trials

Organizations

Research sites